18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

This pilot study at St. Jude is evaluating the safety and biodistribution of 18F-DA in pediatric patients with neuroblastoma or pheochromocytoma, while comparing its imaging clarity with the current standard, 123I-mIBG. Approximately 20 patients will receive an investigational injection of 18F-DA to determine its potential as a superior PET imaging agent.